Long-Term Outcomes of Dose Escalation in Definitive Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized Phase III Trial
Year: 2025
Type: article
Study design: Clinical Trial
Authors: Y. Xu, B. Dong, Q. Cheng, W. Zhu, J. Li, R. Huang, Z. Sun, X. Yang, L. Liu, H. He, Z. Liao, Y. Kong, W. Wang, J. Chen, H. He, G. Qiu, M. Zeng, J. Pu, W. Hu, Y. Bao, Z. Liu, J. Ma, H. Jiang, X. Du, J. Hu, T. Zhuang, J. Huang, T. Hua, Y. Liu, X. Liang, J. Zhou, X. Zheng, B. Chen, M. Xi, M. Chen
Institutions: Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Huaian First People’s Hospital, Nanjing Medical University, Fujian Medical University, Fujian Provincial Cancer Hospital, First People's Hospital of Foshan, Jining First People's Hospital, Jiaxing University, First Hospital of Jiaxing, Quzhou City People's Hospital, The University of Texas MD Anderson Cancer Center, University of Electronic Science and Technology of China, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Jinhua Central Hospital, The First Affiliated Hospital, Sun Yat-sen University, Hunan Cancer Hospital, Anhui Provincial Hospital, First Affiliated Hospital of Bengbu Medical College, Affiliated Hospital of North Sichuan Medical College, Cancer Hospital of Shantou University Medical College, The First People's Hospital of Changzhou, Jiangsu Cancer Hospital, Guangzhou Medical University Cancer Hospital, Guangzhou Medical University, Zhejiang Provincial People's Hospital, First Affiliated Hospital of Soochow University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4414557753